OOIR: Observatory of International Research

Papers

(The H4-Index of Rheumatology is 38. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
Granulomatosis with polyangiitis presenting as obstructive uropathy and vasculitic myopathy	142
Validation of a questionnaire for central nervous system aspects of joint pain: the CAP questionnaire	102
Comment on: Anti-acid therapy in SSc-associated interstitial lung disease: long-term outcomes from the German Network for Systemic Sclerosis—caution is key in interpreting retrospective data: Reply	92
Comment on: Muscle involvement in systemic lupus erythematosus: multimodal ultrasound assessment and relationship with physical performance	77
COVID-19 vaccine affects neither prothrombotic antibody profile nor thrombosis in primary anti-phospholipid syndrome: a prospective study	70
Comment on: Switching from prednisolone to dexamethasone in difficult-to-treat rheumatoid arthritis	65
Comment on: Increased risk of osteoporosis and femoral neck fractures in patients with familial Mediterranean fever—a large retrospective cohort study	63
Genetics of longitudinal kidney function in children and adults with systemic lupus erythematosus	61
Comment on: AI am a rheumatologist: a practical primer to large language models for rheumatologists: reply	60
Boxer’s shape, an unusual finding in nailfold capillaroscopy	57
Will we ever agree on using low-dose glucocorticoids in treating rheumatoid arthritis?	53
Sensorineural hearing loss in anti-interleukin-1 treated CAPS patients: risk factors and real-life barriers—an observational study	52
Editor’s Acknowledgement	52
Correction to: Association of the clinical components in the distal interphalangeal joint synovio-entheseal complex and subsequent response to ixekizumab or adalimumab in psoriatic arthritis	50
The role of IL-23 in joint disease	50
Clinico–pathological phenotypes of systemic sclerosis–associated myopathy: analysis of a large multicentre cohort	49
A case of carpal tunnel syndrome caused by gouty tophi confirmed by dual-source CT	47
Comment on: The association between autoantibodies and risk for venous thromboembolic events among patients with rheumatoid arthritis: reply	46
Prosthetic infections following tocilizumab treatment in patients with rheumatoid arthritis	45
Activation of circulating monocytes by low-density lipoprotein—a risk factor for osteoarthritis?	45
OA22 Methotrexate drug monitoring and referral patterns to Hepatology - can we improve detection and monitoring of hepatoxicity with methotrexate use?	43
Prodromal symptoms of rheumatoid arthritis in a primary care database: variation by ethnicity and socioeconomic status	42
Impaired humoral and T helper cell responses to toxic shock syndrome toxin-1 (TSST-1) in granulomatosis with polyangiitis	42
Effectiveness of intravenous infliximab versus subcutaneous adalimumab in Takayasu arteritis: multicenter retrospective study	42
Comparative risk of blindness and vision-threatening ocular comorbidities in patients with Behçet’s disease versus the general population	41

Enhancing diagnosis of gout with deep learning in dual-energy computed tomography: a retrospective analysis of crystal and artefact differentiation	41
Giant cell arteritis of the prostate	41
The influence of biological DMARDs on aseptic arthroplasty loosening: a retrospective cohort study	40
Neither ultrasound synovitis nor clinical-ultrasound phenotypes of established rheumatoid arthritis predict response to targeted therapy	40
Gastrointestinal manifestations in systemic lupus erythematosus: data from an Indian multi-institutional inception (INSPIRE) cohort	40
Factors associated with delay in the diagnosis and treatment of systemic lupus erythematosus in adult patients: a systematic review	40
A systematic review of patient-reported outcome measures in patients with anti-neutrophil cytoplasmic antibody associated vasculitis	39
Panel sequencing links rare, likely damaging gene variants with distinct clinical phenotypes and outcomes in juvenile-onset SLE	39
Improvement of high-density lipoprotein atheroprotective properties in patients with systemic lupus erythematosus after belimumab treatment	39
Biopsy vs imaging for the diagnosis of giant cell arteritis. Viewpoint 2: in favour of biopsy	39
The 2022 British Society for Rheumatology guideline for the treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs	38
The efficacy of rituximab plus belimumab or telitacicept in refractory lupus nephritis	38
Examination of nailfold videocapillaroscopy findings in ANCA-associated vasculitis	38
The top 10 research priorities in psoriatic arthritis: a James Lind Alliance Priority Setting Partnership	38